Click-to-Chelate: Development of Technetium and Rhenium-Tricarbonyl Labeled Radiopharmaceuticals

por Kluba, Christiane A., Mindt, Thomas L.
Publicado 2013

Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD−L1

por Jouini, Nedra, Cardinale, Jens, Mindt, Thomas L.
Publicado 2022

A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting

por Fischer, Christiane A., Vomstein, Sandra, Mindt, Thomas L.
Publicado 2014

1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity

por Rečnik, Lisa-Maria, Kandioller, Wolfgang, Mindt, Thomas L.
Publicado 2020

Manganese in PET imaging: Opportunities and challenges

por Brandt, Marie, Cardinale, Jens, Rausch, Ivo, Mindt, Thomas L.
Publicado 2019

Theranostics with photodynamic therapy for personalized medicine: to see and to treat

por Wang, Youchao, Staudinger, Johannes Nikodemus, Mindt, Thomas L., Gasser, Gilles
Publicado 2023

Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin (177)Lu-PP-F11N

por Grob, Nathalie M., Schibli, Roger, Béhé, Martin, Mindt, Thomas L.
Publicado 2021

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4

por Kaeppeli, Simon A. M., Schibli, Roger, Mindt, Thomas L., Behe, Martin
Publicado 2019

The Race for Hydroxamate-Based Zirconium-89 Chelators

por Feiner, Irene V. J., Brandt, Marie, Cowell, Joseph, Demuth, Tori, Vugts, Daniëlle, Gasser, Gilles, Mindt, Thomas L.
Publicado 2021

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

por Koziorowski, J., Behe, M., Decristoforo, C., Ballinger, J., Elsinga, P., Ferrari, V., Kolenc Peitl, P., Todde, S., Mindt, T. L.
Publicado 2016

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals

por Todde, S., Peitl, P. Kolenc, Elsinga, P., Koziorowski, J., Ferrari, V., Ocak, E. M., Hjelstuen, O., Patt, M., Mindt, T. L., Behe, M.
Publicado 2017

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals

por Giammei, Carolina, Balber, Theresa, Benčurová, Katarina, Cardinale, Jens, Berroterán-Infante, Neydher, Brandt, Marie, Jouini, Nedra, Hacker, Marcus, Mitterhauser, Markus, Mindt, Thomas L.
Publicado 2020

EANM guideline on the validation of analytical methods for radiopharmaceuticals

por Gillings, Nic, Todde, Sergio, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip, Ferrari, Valentina, Hjelstuen, Olaug, Peitl, Petra Kolenc, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne
Publicado 2020

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines

por Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., Windhorst, Albert D.
Publicado 2018

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines

por Coenen, Heinz H., Gee, Antony D., Adam, Michael, Antoni, Gunnar, Cutler, Cathy S., Fujibayashi, Yasuhisa, Jeong, Jae Min, Mach, Robert H., Mindt, Thomas L., Pike, Victor W., Windhorst, Albert D.
Publicado 2019

Synthesis and Preclinical Evaluation of Radiolabeled [(103)Ru]BOLD-100

por Happl, Barbara, Brandt, Marie, Balber, Theresa, Benčurová, Katarína, Talip, Zeynep, Voegele, Alexander, Heffeter, Petra, Kandioller, Wolfgang, Van der Meulen, Nicholas P., Mitterhauser, Markus, Hacker, Marcus, Keppler, Bernhard K., Mindt, Thomas L.
Publicado 2023

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

por Gillings, Nic, Hjelstuen, Olaug, Ballinger, Jim, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip, Ferrari, Valentina, Peitl, Petra Kolenc, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Neels, Oliver, Ocak, Meltem, Patt, Marianne, Todde, Sergio
Publicado 2021

Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)Zr-immuno-PET

por Vugts, Danielle J., Klaver, Chris, Sewing, Claudia, Poot, Alex J., Adamzek, Kevin, Huegli, Seraina, Mari, Cristina, Visser, Gerard W. M., Valverde, Ibai E., Gasser, Gilles, Mindt, Thomas L., van Dongen, Guus A. M. S.
Publicado 2016

EANM guideline on quality risk management for radiopharmaceuticals

por Gillings, Nic, Hjelstuen, Olaug, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip H., Ferrari, Valentina, Kiss, Oliver C., Kolenc, Petra, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne, Todde, Sergio, Walte, Almut
Publicado 2022

Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical (89)Zr-immuno-PET

por Chomet, Marion, Schreurs, Maxime, Bolijn, Maria J., Verlaan, Mariska, Beaino, Wissam, Brown, Kari, Poot, Alex J., Windhorst, Albert D., Gill, Herman, Marik, Jan, Williams, Simon, Cowell, Joseph, Gasser, Gilles, Mindt, Thomas L., van Dongen, Guus A. M. S, Vugts, Danielle J.
Publicado 2020